Zhongzhi Pharmaceutical Holdings Limited
Research Zhongzhi Pharmaceutical Holdings Limited (3737.HK) on Bullrun: market cap HKD 548.43M, P/E 32.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3737.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 548.43M
- P/E32.5
Valuation Snapshot
latest market cap is HKD 548.43M; P/E is 32.5.
Peer valuation comparison
Latest P/E is 32.5x versus a Healthcare sector median of 21.8x (49.1% above).
Latest P/E is 32.5x versus a China median of 16.28x (99.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | CNY 2.21B | CNY 95.21M | CNY 39.62M | 58.2% | 0.11 | CNY 167.10M | CNY 301.18M | CNY 1.12B |
| FY2023 | CNY 2.05B | CNY 162.78M | -CNY 69.93M | 59.4% | 0.19 | CNY 164.37M | CNY 225.06M | CNY 1.05B |
| FY2022 | CNY 1.83B | CNY 106.39M | CNY 195.43M | 58.7% | 0.13 | CNY 381.01M | CNY 211.41M | CNY 1.00B |
| FY2021 | CNY 1.75B | CNY 52.13M | -CNY 9.48M | 60.8% | 0.06 | CNY 233.38M | CNY 175.74M | CNY 898.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 548.43M | 32.5 | n/a | 0.05 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.05 HKD.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.05 CNY |
| FY2024 | 0.03 CNY |
| FY2023 | 0.15 CNY |
About Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zhongzhi Pharmaceutical Holdings Limited's market cap?
Zhongzhi Pharmaceutical Holdings Limited's market capitalization is HKD 548.43M.
What is Zhongzhi Pharmaceutical Holdings Limited's P/E ratio?
Zhongzhi Pharmaceutical Holdings Limited's price-to-earnings (P/E) ratio is 32.5.
What does Zhongzhi Pharmaceutical Holdings Limited do?
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management.